Indapamide, perindopril tert-butylamine
Sold as Perdotor plus, Vectoryl plus, Prexum plus, Acesyl co, Peristar co, Ciplasyl plus, Pearinda plus
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 5
- Registrations
- 9
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Servier Laboratories South Africa (Pty) Ltd | Perdotor plus, Vectoryl plus, Prexum plus | Not stated | 380026, 380027, 380028 | Not determined | None |
| Ascendis Pharma (Pty) Ltd | Acesyl co | 2/0,625, 4/1,25 | 411047, 411048 | Not determined | None |
| Adcock ingram limited | Peristar co | 2/0,625, 4/1,25 | 440501, 440502 | Not determined | None |
| Zydus Healthcare (Pty) Ltd | Ciplasyl plus | 4 | 440503 | Not determined | None |
| Pharma Dynamics (Pty) Ltd | Pearinda plus | 8 mg | 490013 | S3 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Perdotor plus EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL TERT-BUTYLAMINE 4,0 mg | Not listed | 38002638/7.1.3/0026 | Registered | Not determined | None |
| Vectoryl plus EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL TERT-BUTYLAMINE 4,0 mg | Not listed | 38002738/7.1.3/0027 | Registered | Not determined | None |
| Prexum plus EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL TERT-BUTYLAMINE 4,0 mg | Not listed | 38002838/7.1.3/0028 | Registered | Not determined | None |
| Acesyl co 2/0,625 EACH TABLET CONTAINS INDAPAMIDE 0,625 mg PERINDOPRIL TERT-BUTYLAMINE 2,0 mg | 2/0,625 | 41104741/7.1.3/1047 | Registered | Not determined | None |
| Acesyl co 4/1,25 EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL TERT-BUTYLAMINE 4,0 mg | 4/1,25 | 41104841/7.1.3/1048 | Registered | Not determined | None |
| Peristar co 2/0,625 EACH TABLET CONTAINS INDAPAMIDE 0,625 mg PERINDOPRIL TERT-BUTYLAMINE 2,0 mg | 2/0,625 | 44050144/7.1.3/0501 | Registered | Not determined | None |
| Peristar co 4/1,25 EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL TERT-BUTYLAMINE 4,0 mg | 4/1,25 | 44050244/7.1.3/0502 | Registered | Not determined | None |
| Ciplasyl plus 4 tablets EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL TERT-BUTYLAMINE 4,0 mg | 4Tablets | 44050344/7.1.3/0503 | Registered | Not determined | None |
| Pearinda plus 8 | 8 mgTablets. | 49001349/7.1.3/0013Approved 9 January 2025 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Pearinda plus 8, Pharma Dynamics (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.